This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Career Center   |   Print Page   |   Contact Us   |   Sign In   |   Join SRNT
2020 Keynote Plenary Lectures
President's Symposium on Adolescent Tobacco Use Cessation

Date: Wednesday, March 11, 2020

Time: 5:30 pm - 6:45 pm

Chair: Suzanne M. Colby, PhD; Professor of Psychiatry and Human Behavior and Postdoctoral Training Director at the Center for Alcohol & Addiction Studies, Brown University School of Public Health; Providence, RI

Presenters: Ahmed Jamal, MBBS, CDC Office on Smoking and Health; Suchitra Krishnan-Sarin, PhD, Yale University; Robin Mermelstein, PhD, University of Illinois at Chicago

Opening Plenary Overview: This symposium focuses on the persistent and evolving challenge of effectively addressing adolescent tobacco use cessation. Presentations will consider youth tobacco use in all its forms, including multiple tobacco product use. Dr. Jamal will draw on both U.S. and international data from multiple sources to describe the current nature of youth tobacco use, dependence, motivation to quit and actual quit attempts, all of which have relevance for determining potential need and demand for treatment. Dr. Krishnan-Sarin will summarize key findings from prior youth tobacco cessation research, and will review what is known about e-cigarette appeal in youth, and then will consider how this knowledge can inform intervention development. Dr. Mermelstein will discuss the dual developmental contexts (i.e., adolescence as a life stage; and initiation and progression as stages of the tobacco use continuum) that are essential considerations for youth tobacco cessation treatment development and implementation. Dr. Colby will moderate Q&A with the panel following the presentations.

Ahmed Jamal, MBBS, CDC Office on Smoking and Health: Dr. Jamal is a physician by training that has completed fellowship in infectious diseases (ICDDR, Bangladesh), and post-graduate diploma in cardiology (Middlesex University, UK). He received his MBBS (MD-equivalent) from the University of Dhaka (Bangladesh), and MPH in Epidemiology from the University of Hawaii. He is a lead epidemiologist and the Surveillance Team lead in CDC's Office on Smoking and Health. Prior to joining CDC in 2010, he served as the Director of the Surveillance and Epidemiology unit in the Diabetes Prevention and Control Program in the New York City Department of Health where he led the expansion of the NYC A1C Registry. He has also served as an epidemiologist in the Georgia Division of Public Health, the Michigan Department of Community Health, and the Hawaii Health Department. In his current role, Dr. Jamal leads the CDC team that administers the National Youth Tobacco Survey and oversees the surveillance activities for reporting on tobacco product use, attitudes, and behaviors among U.S. youth and adults.

Suchitra Krishnan-Sarin, PhD, Yale University: Dr. Suchitra Krishnan-Sarin is a Professor of Psychiatry at Yale School of Medicine. Her research is focused on understanding the biology and behavior underlying addictions, with the goal of developing optimal treatments for teenage and adult users. Dr. Krishnan-Sarin leads the NIH and FDA funded Tobacco Center of Regulatory Science at Yale which is developing scientific evidence to support tobacco regulation. Her research on youth tobacco use has used focus groups and surveys to understand patterns and perceptions of use of tobacco products, clinical trials to develop and test the use of novel behavioral and pharmacological interventions, and neuroimaging tools to understand neural predictors of treatment response. Dr. Krishnan-Sarin has contributed to the Surgeon General’s report on “Preventing Tobacco Use among Young People” and served as a member of the FDA’s Tobacco Product Scientific Advisory Committee. She has been involved in many efforts to educate the public about concerns related to tobacco and e-cigarette use by youth, including through a TEDMED talk, congressional and other federal briefings, media and community presentations, numerous education programs for students, parents and teachers, as well as local and federal regulatory efforts.

Robin Mermelstein, PhD, University of Illinois at Chicago: Robin Mermelstein, Ph.D. is Distinguished Professor, Department of Psychology, the Director of the Institute for Health Research and Policy, and the Co-Director of the Center for Clinical and Translational Science at the University of Illinois at Chicago. Her research has focused on understanding the etiology and progression of tobacco use in adolescents and young adults, in developing interventions to reduce tobacco use and increase cessation in both adolescents and in young adults, and in translating research into practice and policy. Much of her research has addressed the question of adolescent and young adult tobacco use; understanding the development and trajectories of tobacco use; using ecological momentary assessment to examine the immediate contexts surrounding smoking and to understand, in-depth a variety of combinations of tobacco use, with an emphasis over the past five years on use of both e-cigarettes and cigarettes, and transitions between products. She is a past President of the Society for Research on Nicotine and Tobacco.

Basic Science Keynote Plenary on Mechanisms of Addiction in Adolescence

Date: Thursday, March 12, 2020

Time: 8:30 am - 9:30 am

Presenter: Mary Heitzeig, PhD; Associate Professor, Addiction Center, Department of Psychiatry, University of Michigan; Ann Arbor, Michigan

Mary Heitzeg is an Associate Professor in the Department of Psychiatry and Addiction Center at the University of Michigan. Dr. Heitzeg’s primary research focus is on developmental neuroimaging targeted at investigating two related themes relevant to adolescent substance use: 1) how early individual differences in brain function relate to susceptibility to alcohol and other drug use and problems; and 2) how substance use impacts the developing brain and, in consequence, risk trajectories across adolescence. She is PI of the ongoing neuroimaging component of the Michigan Longitudinal Study, a prospective, high-risk study of the emergence of risk and the development of alcohol use disorder and related symptomatology. She is also PI of the University of Michigan site for the Adolescent Brain Cognitive Development (ABCD) Study, which is tracking neural and behavioral development through adolescence in over 11,000 youth across the country.

Public Health Keynote Plenary and Recipient of the 2020 Doll-Wynder Award: How Can Tobacco or Nicotine Harm Reducing Products Contribute to Eradicating the Global Scourge Caused by Tobacco?

Date: Thursday, March 12, 2020

Time: 1:30 pm - 2:30 pm

Presenter: Ann McNeill, PhD; Professor of Tobacco Addiction, Institute of Psychiatry, Psychology & Neuroscience (loPPN), King's College London; & Vice Dean (Culture, Diversity & Inclusion), loPPN; London, UK

Ann McNeill is Professor of Tobacco Addiction and Vice Dean (Culture, Diversity & Inclusion), Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London. The focus of Ann’s research is largely on reducing the population level impact of smoking through the application of tobacco control policies and interventions, including harm reduction strategies. Ann has a particular focus on reducing the health inequalities caused by smoking, including the higher levels of smoking in disadvantaged groups such as those with mental health problems. Ann is an NIHR Senior Investigator and a Thomson Reuters highly cited scientist in the science and social science category.

Clinical Keynote Plenary on Smoking Cessation: the Challenge of Implementation

Date: Friday, March 13, 2020

Time: 10:30 am - 11:30 am

Presenter: Paul Aveyard, PhD; Professor of Behavioural Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford; Oxford, UK

Paul Aveyard is a practising GP and professor of behavioural medicine at the University of Oxford, UK. His work on tobacco control concerns mostly trials on smoking cessation and harm reduction. These have included behavioural and pharmacological interventions and combined strategies. Paul is a former chair of Cancer Research UK’s Tobacco Advisory Group. He is a past president of the UK Society for Behavioural Medicine and a senior editor of Addiction and coordinating editor of the Cochrane Tobacco Addiction Group.

Jarvik-Russell New Investigator Keynote Plenary and Recipient of the 2020 Jarvik Russell Award: Science to Inform Tobacco Product Regulation

Date: Friday, March 13, 2020

Time: 1:00 pm - 1:30 pm

Presenter: Tracy Smith, PhD; Assistant Professor, Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina; Research Member; Cancer Control and Prevention, Hollings Cancer Center; Charleston, SC

Dr. Tracy Smith is an Assistant Professor at the Medical University of South Carolina. Dr. Smith earned her PhD in Biological and Health Psychology from the University of Pittsburgh in 2015. Over the past 8 years, Dr. Smith’s research has been exclusively devoted to the field of nicotine and tobacco, and this research has focused on improving public health by moving smokers away from combustible tobacco products using tobacco regulation and product standards. This research falls into two primary areas: 1) a tobacco policy that would reduce how much nicotine is in cigarettes to a minimally addictive level, and 2) a newer line of work which focuses on the product characteristics that determine uptake of e-cigarettes among current smokers. Her research has spanned the methodological spectrum and includes preclinical research, human lab studies, inpatient trials, and large clinical trials. To date, Dr. Smith has published 39 peer-reviewed papers, all of which have been thematically related to tobacco regulatory science. She has been awarded an F31, R03, and K01 all related to tobacco regulatory science and this work has been funded by NIDA, NCI, and the FDA Center for Tobacco Products.

Policy Keynote Plenary: Report on Smoking Cessation

Date: Friday, March 13, 2020

Time: 1:30 pm - 2:45 pm

Presenter: U.S. Surgeon General Vice Admiral Jerome M. Adams, MD, MPH

“We are privileged that Surgeon General Dr. Adams, who has a commitment to the reduction of tobacco use in the United States, and who has pledged, among other things, to follow the science, has agreed to address our membership at the SRNT Annual Meeting,” said SRNT’s President Suzanne Colby, PhD. "To have the U.S. Surgeon General, himself, present findings from his office’s most recent report focusing on smoking cessation is truly an honor."

Dr. Adams is the 20th Surgeon General of the United States. His mission as the “Nation’s Doctor,” is to advance the health of the American people. Dr. Adams’ motto as Surgeon General is “better health through better partnerships.” He is committed to strengthening relationships with all members of the health community, and forging new partnerships with members from the business, faith, education and public safety and national security communities.

During his tenure as U.S. Surgeon General, Dr. Adams has created several initiatives to tackle our nation’s most pressing health issues, including: the opioid epidemic, oral health, and the links between community health and both economic prosperity and national security.

Dr. Adams has been a leader in numerous professional organizations, including the American Medical Association, the Indiana State Medical Association and the Indiana Society of Anesthesiologists. Dr. Adams is also the former Health Commissioner of Indiana, where he led the State’s responses to Ebola, Zika, and to the largest ever HIV outbreak in the United States related to injection drug use.

Connect With Us
Membership Management Software Powered by YourMembership  ::  Legal